News
PEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...
In a letter, the Long Beach Democrat asked Health and Human Services Secretary Robert F. Kennedy Jr. to produce documents ...
The resulting show enjoyed a two-year run. After a brief hiatus, during which Hampton moved to California, the play was ...
A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...
New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...
Hosted on MSN23d
HIV Activists Organize to Save Lives as Trump Guts FundingThen she referenced the 1980s cartoon where heroes combine forces to ... into a manageable chronic disease in which a person's virus levels are so suppressed that they cannot spread HIV to others. And ...
Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...
Scientists found a way to make the HIV virus visible, potentially laying the groundwork for ways to banish it from the body altogether.
Australian researchers have taken a major step towards an HIV cure by devising a method to deliver an mRNA-based therapy direct to cells to expose the dormant virus where it hides. Major advances ...
Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load significantly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results